View Rapid Detection
View Analytical Services
View In Vitro Technologies
Celsis is a world leading provider of innovative life science products and laboratory services to the pharmaceutical, biopharmaceutical, and consumer products industries through its three business areas; rapid detection, analytical and drug development services and ADME-Tox in vitro technologies. Each division of Celsis International plc has the capacity to deliver substantial time and cost savings to its customers, in addition to ensuring product quality and safety for consumers.
27 March 2008 - Signs Exclusive Agreement with Apath LLC
27 March 2008 - Pre Close Trading Update
11 February 2008 - Celsis In Vitro Technologies Introduces New Assay-Specific Human Liver Microsomes
7 February 2008 - Interim Management Statement
6 August 2007 - Celsis Rapid Detection Testing Supports FDA Approval of GlaxoSmithKline's New Drug Application
 
Copyright©2006 Celsis International plc, All Rights Reserved   Privacy Policy